Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
for source : Www.admabiologics.com save search
ADMA BioCenters Receives FDA Approval for its Eighth Plasma Collection Center, Located in Hammond, LA
Published: 2023-02-08 (Crawled : 12:00) - admabiologics.com
ADMA 4 | $6.27 1.13% 1.12% 3.4M
|
Health Technology
|
| O: 0.78%
H: 0.0%
C: -2.57%
fda approval
ADMA Biologics Announces FDA Approval for Room Temperature Storage of ASCENIV™ & BIVIGAM®
Published: 2022-12-13 (Crawled : 12:00) - admabiologics.com
ADMA 4 | $6.27 1.13% 1.12% 3.4M
|
Health Technology
|
| O: 0.55%
H: 2.45%
C: 1.09%
bivigam fda approval
ADMA BioCenters Receives FDA Approval for its Seventh Plasma Collection Center, Located in Greensboro, NC
Published: 2022-10-31 (Crawled : 11:00) - admabiologics.com
ADMA 4 | $6.27 1.13% 1.12% 3.4M
|
Health Technology
|
| O: 0.71%
H: 0.26%
C: -0.7%
fda approval
ADMA Biologics Announces FDA Approval of Extended Shelf Life for ASCENIV™ & BIVIGAM<sup>®</sup> from 24 to 36 Months
Published: 2022-03-25 (Crawled : 21:00) - admabiologics.com
ADMA 4 | $6.27 1.13% 1.12% 3.4M
|
Health Technology
|
| O: 1.33%
H: 7.24%
C: 7.24%
fda life approval
ADMA BioCenters Receives FDA Approval for its Sixth Plasma Collection Center, Located in Myrtle Beach, SC
Published: 2022-06-27 (Crawled : 12:00) - admabiologics.com
ADMA 4 | $6.27 1.13% 1.12% 3.4M
|
Health Technology
|
| O: -0.74%
H: 6.93%
C: 6.93%
fda approval
ADMA Biologics Announces FDA Approval of Extended Shelf Life for ASCENIV™ & BIVIGAM® from 24 to 36 Months
Published: 2022-03-25 (Crawled : 11:00) - admabiologics.com
ADMA 4 | $6.27 1.13% 1.12% 3.4M
|
Health Technology
|
| O: 1.33%
H: 7.24%
C: 7.24%
bivigam fda approval
ADMA BioCenters Receives FDA Approval for its Fifth Plasma Collection Center, Located in Conyers, GA
Published: 2022-03-07 (Crawled : 22:00) - admabiologics.com
ADMA 4 | $6.27 1.13% 1.12% 3.4M
|
Health Technology
|
| O: 0.0%
H: 3.59%
C: 1.8%
fda fda approval approval
ADMA BioCenters Receives FDA Approval for its Fourth Plasma Collection Center Located in Goose Creek, SC
Published: 2022-01-18 (Crawled : 12:00) - admabiologics.com
ADMA 4 | $6.27 1.13% 1.12% 3.4M
|
Health Technology
|
| O: 7.34%
H: 0.0%
C: 0.0%
fda fda approval approval
ADMA Biologics Announces Pricing of Public Offering for $50 Million of Common Stock
Published: 2021-10-21 (Crawled : 13:00) - admabiologics.com
ADMA 4 | $6.27 1.13% 1.12% 3.4M
|
Health Technology
|
| O: -7.93%
H: 24.27%
C: 18.4%
offering
ADMA Biologics Announces a Poster Presentation at the 2021 International Society for Influenza and other Respiratory Virus Diseases - World Health Organization Conference
Published: 2021-10-19 (Crawled : 11:00) - admabiologics.com
ADMA 4 | $6.27 1.13% 1.12% 3.4M
|
Health Technology
|
| O: 0.91%
H: 1.8%
C: 0.0%
presentation disease respiratory influenza conference
ADMA Biologics Receives FDA Approval for VanRx Aseptic Fill-Finish Machine and Related Operations
Published: 2021-09-08 (Crawled : 11:00) - admabiologics.com
ADMA 4 | $6.27 1.13% 1.12% 3.4M
|
Health Technology
|
| O: 10.24%
H: 0.71%
C: -15.71%
fda fda approval approval
ADMA Biologics Receives FDA Approval for ADMA BioCenters Plasma Collection Facility in Maryville, TN
Published: 2021-08-16 (Crawled : 11:00) - admabiologics.com
ADMA 4 | $6.27 1.13% 1.12% 3.4M
|
Health Technology
|
| O: 10.6%
H: 2.4%
C: -13.77%
fda fda approval approval
ADMA Biologics Advances Expansion Plans and Opens New Plasma Collection Center in Conyers, GA; ADMA Implements Haemonetics’ Persona Technology for NexSys Plasma Collection System
Published: 2021-08-10 (Crawled : 21:00) - admabiologics.com
HAE | $81.24 -2.66% -1.65% 850K
|
Health Technology
|
| O: 1.33%
H: 6.49%
C: 5.88%
ADMA 4 | $6.27 1.13% 1.12% 3.4M
|
Health Technology
|
| O: -0.65%
H: 1.31%
C: 0.0%
expansion technology
ADMA Biologics Announces Commercial Availability of Expanded Vial Size Offerings for BIVIGAM® and NABI-HB®
Published: 2021-08-09 (Crawled : 11:00) - admabiologics.com
ADMA 4 | $6.27 1.13% 1.12% 3.4M
|
Health Technology
|
| O: 2.56%
H: 0.63%
C: -3.13%
offering commercialization
ADMA Biologics Receives FDA Approval for Increased IVIG Production Scale
Published: 2021-04-28 (Crawled : 16:23) - admabiologics.com
ADMA 4 | $6.27 1.13% 1.12% 3.4M
|
Health Technology
|
| O: 24.21%
H: 11.44%
C: -12.29%
fda fda approval approval
Gainers vs Losers
| 67% | 33% |
Top 10 Gainers
Your saved searches
Save your searches and get alerts when important news are released.